↓ Skip to main content

Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review

Overview of attention for article published in Supportive Care in Cancer, December 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
23 Mendeley
Title
Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review
Published in
Supportive Care in Cancer, December 2011
DOI 10.1007/s00520-011-1318-2
Pubmed ID
Authors

David H. Henry, Corey J. Langer, R. Scott McKenzie, Catherine Tak Piech, Mekré Senbetta, Kathy L. Schulman, Edward J. Stepanski

Abstract

In July 2007, the Centers for Medicare and Medicaid Services (CMS) limited coverage of erythropoiesis-stimulating agents (ESAs) in cancer patients with chemotherapy-induced anemia (CIA) through a National Coverage Determination (NCD). The primary objective of this study was to compare transfusion rates in patients with CIA with lung, breast, or colorectal cancer before and after the NCD.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 26%
Student > Bachelor 4 17%
Other 3 13%
Lecturer 2 9%
Student > Ph. D. Student 2 9%
Other 2 9%
Unknown 4 17%
Readers by discipline Count As %
Medicine and Dentistry 10 43%
Nursing and Health Professions 4 17%
Sports and Recreations 1 4%
Unknown 8 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2011.
All research outputs
#18,301,870
of 22,659,164 outputs
Outputs from Supportive Care in Cancer
#3,540
of 4,517 outputs
Outputs of similar age
#196,410
of 242,066 outputs
Outputs of similar age from Supportive Care in Cancer
#18
of 24 outputs
Altmetric has tracked 22,659,164 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,517 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,066 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.